Recent 8-K filings for NNVC

• May 21, 2026, 6:01 AM ET other material materiality 0.55 neutral item 7.01

  NanoViricides says NV-387 and NV-387-remdesivir expected to be effective against Ebola Bundibugyo strain in DRC

  NV-387 is broad-spectrum antiviral entering Phase II for Mpox in DRC.

• May 20, 2026, 4:30 PM ET other material materiality 0.60 neutral item 1.01item 8.01item 9.01

  NanoViricides raises $2M in registered direct offering of shares and warrants

  Offering of 1,333,334 shares (or pre-funded warrants) plus 1,333,334 warrants at $1.75, priced at $1.50 per share.

• November 26, 2025, 6:59 PM ET other materiality 0.10 neutral item 5.07

  NanoViricides annual meeting approves director re-election, executive compensation, auditor ratification

  Anil Diwan re-elected as Class I Director with 9,757,652 votes in favor, 173,096 against.

• November 14, 2025, 6:59 PM ET other material materiality 0.60 neutral item 1.01item 3.02item 8.01item 9.01 ◈ Equity Issuances

  NanoViricides raises $6M in registered direct offering and private placement with warrants

  Offered 3,571,429 shares (or pre-funded equivalents) at $1.68/share for gross proceeds of ~$6M.

• October 1, 2025, 7:59 PM ET leadership materiality 0.40 neutral item 5.02

  NanoViricides extends CEO/CFO contracts; raises CEO line of credit to $3M through 2027

  President/CEO Diwan term extended to June 30, 2026; base salary $400,000/yr; granted 10,204 Series A preferred shares vesting quarterly.

• December 12, 2024, 6:59 PM ET other materiality 0.15 neutral item 5.07

  NanoViricides shareholders re-elect three directors and ratify auditor at 2024 annual meeting

  Theodore Rokita re-elected with 2,060,147 votes for, 166,389 against.

• August 9, 2024, 7:59 PM ET other material materiality 0.50 neutral item 5.02

  NanoViricides extends President Diwan ($400k, 10k Series A shares) and CFO Vyas through June 2025

  President Anil Diwan's employment extended to June 30, 2025 at $400,000 base salary.

• April 5, 2024, 7:59 PM ET other material materiality 0.40 neutral item 1.01 ◈ Material Agreements

  NanoViricides names EF Hutton as sole sales agent for $50M ATM, removes B. Riley

  EF Hutton LLC becomes sole agent under existing $50M at-the-market offering; B. Riley Securities removed.

• February 16, 2024, 6:59 PM ET other material materiality 0.55 positive item 1.01 ◈ Material Agreements ×5

  NanoViricides defers TheraCour milestone payments until revenue; CEO extends Line of Credit

  Amendment to TheraCour license defers future cash milestone payments (Milestones 4-7) until company achieves a Revenue Event; capped at 50% of Recognized Revenue.

• January 19, 2024, 6:59 PM ET other material materiality 0.15 neutral item 5.07 ◈ Shareholder Votes ×4

  NanoViricides shareholders re-elect Anil Diwan as director, approve executive compensation and preferred stock grant

  At the January 13, 2024 annual meeting, shareholders re-elected Anil Diwan as Class I director with 5,590,467 votes for, 308,092 against, 488,175 abstentions, and 3,056,966 broker non-votes.

Materiality & sentiment trend

Max materiality 0.60 · Median 0.45 · Most common event other_material

1 positive 0 negative 9 neutral

source · NNVC on sec.gov